First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastasis ◽

Growth Factor Receptor ◽

Wild Type ◽

First Line ◽

Anaplastic Lymphoma ◽

CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma

European Journal of Radiology ◽

10.1016/j.ejrad.2021.109710 ◽

2021 ◽

pp. 109710

Author(s):

Jooae Choe ◽

Sang Min Lee ◽

Wooil Kim ◽

Kyung-Hyun Do ◽

Seonok Kim ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Impact of tumor epidermal growth factor receptor (EGFR) status on the outcomes of first-line FOLFOX-4 ± cetuximab in patients (pts) with RAS-wild-type (wt) metastatic colorectal cancer (mCRC) in the randomized phase 3 TAILOR trial

Annals of Oncology ◽

10.1093/annonc/mdw370.75 ◽

2016 ◽

Vol 27 ◽

pp. vi174 ◽

Cited By ~ 2

Author(s):

S. Qin ◽

J. Xu ◽

L. Wang ◽

Y. Cheng ◽

T. Liu ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Wild Type ◽

First Line ◽

Phase 3 ◽

A Case of Synchronous Multiple Primary Lung Adenocarcinomas Harboring Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Rearrangement Successfully Treated with Combination of Osimertinib and Alectinib

Respiratory Medicine Case Reports ◽

10.1016/j.rmcr.2021.101418 ◽

2021 ◽

pp. 101418

Author(s):

Yukihisa Inoue ◽

Osamu Matsubara ◽

Yumi Ohira ◽

Satoshi Endo ◽

Yasuto Jinn

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Anaplastic Lymphoma Kinase Rearrangement ◽

Multiple Primary ◽

Epidermal Growth ◽

Lung Adenocarcinomas

Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation coexisting in Chinese patients with lung adenocarcinoma

Thoracic Cancer ◽

10.1111/1759-7714.12111 ◽

2014 ◽

Vol 5 (5) ◽

pp. 411-416 ◽

Cited By ~ 1

Author(s):

Jianfei Zhu ◽

Ling Cai ◽

Haoxian Yang ◽

Yinsheng Wen ◽

Junye Wang ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Chinese Patients ◽

Anaplastic Lymphoma ◽

Anaplastic Lymphoma Kinase Rearrangement ◽

Efficacy of icotinib versus traditional chemotherapy as first-line treatment for preventing brain metastasis from advanced lung adenocarcinoma in patients with epidermal growth factor receptor-sensitive mutation

Journal of Cancer Research and Therapeutics ◽

10.4103/0973-1482.145851 ◽

2014 ◽

Vol 10 (7) ◽

pp. 155 ◽

Cited By ~ 4

Author(s):

Fang Li ◽

Nan Du ◽

Xiao Zhao ◽

Guangqin Zhu ◽

Huoming Chen ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastasis ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Line Treatment ◽

First Line ◽

Epidermal Growth ◽

First Line Treatment

Epidermal growth factor receptor and anaplastic lymphoma kinase mutation in adenocarcinoma lung: Their incidence and correlation with histologic patterns

Indian Journal of Pathology and Microbiology ◽

10.4103/ijpm.ijpm_516_16 ◽

2019 ◽

Vol 62 (1) ◽

pp. 24 ◽

Cited By ~ 1

Author(s):

Meenakshi Swain ◽

Pankaj Gupta ◽

Swarnalata Gowrishankar

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Epidermal Growth ◽

Kinase Mutation

Abstract 1212: Co-targeting epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase overcomes EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models

10.1158/1538-7445.am2017-1212 ◽

2017 ◽

Author(s):

Xiaoming Ouyang ◽

Ashley Barling ◽

Aletha Lesch ◽

Jeffrey Tyner ◽

Sophia Jeng ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Egfr Inhibitor ◽

Anaplastic Lymphoma ◽

Epidermal Growth ◽

Inhibitor Resistance

The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma

10.1183/13993003.congress-2015.pa4250 ◽

2015 ◽

Author(s):

Chung-Jen Huang ◽

Wen-Hui Ku

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Heterogeneity of epidermal growth factor receptor mutations in lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements: A case report

Oncology Letters ◽

10.3892/ol.2014.2468 ◽

2014 ◽

Vol 8 (5) ◽

pp. 2093-2095

Author(s):

QIONG SUN ◽

JIAN-YU WU ◽

SHUN-CHANG JIAO

Keyword(s):

Case Report ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer

European Journal of Cancer ◽

10.1016/j.ejca.2016.07.019 ◽

2016 ◽

Vol 67 ◽

pp. 11-20 ◽

Cited By ~ 34

Author(s):

Volker Heinemann ◽

Fernando Rivera ◽

Bert H. O'Neil ◽

Sebastian Stintzing ◽

Reija Koukakis ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Wild Type ◽

First Line ◽

Efficacy Data ◽